loading
Schlusskurs vom Vortag:
$1.85
Offen:
$1.9
24-Stunden-Volumen:
6,102
Relative Volume:
0.23
Marktkapitalisierung:
$32.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.91M
KGV:
-9.9075
EPS:
-0.1837
Netto-Cashflow:
-
1W Leistung:
-12.92%
1M Leistung:
-19.47%
6M Leistung:
-34.53%
1J Leistung:
+69.30%
1-Tages-Spanne:
Value
$1.80
$1.90
1-Wochen-Bereich:
Value
$1.80
$2.11
52-Wochen-Spanne:
Value
$0.9501
$12.68

Incannex Healthcare Inc Stock (IXHL) Company Profile

Name
Firmenname
Incannex Healthcare Inc
Name
Telefon
61 409 840 786
Name
Adresse
401 DOCKLANDS DRIVE, DOCKLANDS, VICTORIA
Name
Mitarbeiter
9
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
IXHL's Discussions on Twitter

Vergleichen Sie IXHL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
IXHL
Incannex Healthcare Inc
1.82 32.82M 0 -21.91M 0 -0.1837
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
176.74 80.59B 9.15B 2.43B 2.31B 4.92
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.72 44.17B 14.26B 1.55B 0 0.3327
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.57 42.61B 30.27B 1.93B 3.45B 0.444
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.57 18.77B 16.77B -959.00M 1.37B -2.00
Drug Manufacturers - Specialty & Generic icon
VTRS
Viatris Inc
13.22 15.73B 15.05B -883.30M 1.89B 1.53

Incannex Healthcare Inc Aktie (IXHL) Neueste Nachrichten

pulisher
Nov 23, 2024

Incannex Healthcare Inc. Reports Earnings Results for the First Quarter Ended September 30, 2024 - Marketscreener.com

Nov 23, 2024
pulisher
Nov 19, 2024

Incannex Healthcare (NASDAQ:IXHL) Shares Up 5.5% – Still a Buy? - Defense World

Nov 19, 2024
pulisher
Nov 19, 2024

Incannex Healthcare (NASDAQ:IXHL) Trading Up 5.5%What's Next? - MarketBeat

Nov 19, 2024
pulisher
Nov 15, 2024

Incannex Healthcare Inc (IXHL) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 14, 2024

Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business Updates - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

Incannex Secures $59M Financing, Reports Q1 Results Amid Clinical Trial Progress | IXHL Stock News - StockTitan

Nov 14, 2024
pulisher
Oct 25, 2024

Incannex Healthcare names Lou Barbato as chief medical officer - MSN

Oct 25, 2024
pulisher
Oct 24, 2024

Incannex appoints new chief medical officer - Investing.com India

Oct 24, 2024
pulisher
Oct 24, 2024

Incannex appoints new chief medical officer By Investing.com - Investing.com South Africa

Oct 24, 2024
pulisher
Oct 24, 2024

Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical Officer - GlobeNewswire

Oct 24, 2024
pulisher
Oct 24, 2024

Incannex Healthcare Appoints Dr. Barbato as CMO - TipRanks

Oct 24, 2024
pulisher
Oct 22, 2024

Incannex Healthcare Leads The Charge On US Penny Stocks With 2 Other Notable Picks - Simply Wall St

Oct 22, 2024
pulisher
Oct 22, 2024

Incannex Healthcare secures $3.3 million through debt financing By Investing.com - Investing.com Australia

Oct 22, 2024
pulisher
Oct 21, 2024

Incannex Healthcare secures $3.3 million through debt financing - Investing.com

Oct 21, 2024
pulisher
Oct 17, 2024

Incannex Healthcare secures A$6.9 million funding By Investing.com - Investing.com Australia

Oct 17, 2024
pulisher
Oct 15, 2024

Incannex Healthcare secures A$6.9 million funding - Investing.com

Oct 15, 2024
pulisher
Oct 03, 2024

Incannex Provides Business Updates and Progress on OSA Drug Candidate in Phase 2/3 Trials - Sleep Review

Oct 03, 2024
pulisher
Oct 02, 2024

Stonegate Initiates Coverage on Incannex Healthcare Inc. (IXHL) - Invezz

Oct 02, 2024
pulisher
Oct 01, 2024

R&D tax breaks buoy Incannex as losses narrow - Green Market Report

Oct 01, 2024
pulisher
Sep 30, 2024

Incannex Healthcare Inc. (NASDAQ:IXHL) Sees Significant Growth in Short Interest - Defense World

Sep 30, 2024
pulisher
Sep 30, 2024

Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business Updates - The Manila Times

Sep 30, 2024
pulisher
Sep 13, 2024

Incannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Update - MarketBeat

Sep 13, 2024
pulisher
Sep 11, 2024

Incannex Secures Up to $60M in Financing to Support Clinical Trials - Sleep Review

Sep 11, 2024
pulisher
Sep 10, 2024

Incannex secures financing deal valued at US$60 million - Mugglehead

Sep 10, 2024
pulisher
Sep 10, 2024

Incannex $60 Million Deal With Arena For Late-Stage Drug TrialsIncannex Healthcare (NASDAQ:IXHL) - Benzinga

Sep 10, 2024
pulisher
Sep 10, 2024

Incannex Healthcare secures $60 million funding via equity and debt - Investing.com

Sep 10, 2024
pulisher
Sep 10, 2024

Incannex Healthcare secures $60 million funding via equity and debt By Investing.com - Investing.com UK

Sep 10, 2024
pulisher
Sep 10, 2024

Incannex Healthcare lands $60 million financing deal - Green Market Report

Sep 10, 2024
pulisher
Sep 10, 2024

Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena Investors - GlobeNewswire

Sep 10, 2024
pulisher
Sep 10, 2024

Incannex secures $60 million in funding for clinical trials - Investing.com

Sep 10, 2024
pulisher
Aug 29, 2024

Incannex Healthcare Inc. (NASDAQ:IXHL) Sees Large Growth in Short Interest - MarketBeat

Aug 29, 2024
pulisher
Aug 15, 2024

Thinking about buying stock in Altimmune, UiPath, Incannex Healt - GuruFocus.com

Aug 15, 2024
pulisher
Aug 09, 2024

Virtu Financial LLC Buys New Shares in Incannex Healthcare Inc. (NASDAQ:IXHL) - Defense World

Aug 09, 2024
pulisher
Aug 06, 2024

4 Psychedelic Stocks to Consider as Clinical Trials Heat up - Investing.com

Aug 06, 2024
pulisher
Aug 05, 2024

FDA Review of PsiGAD2 IND complete; clinical trial for - GlobeNewswire

Aug 05, 2024
pulisher
Aug 05, 2024

FDA Clears Incannex To Proceed With Phase 2 Psilocybin-Assisted Therapy Trial For Anxiety - Benzinga

Aug 05, 2024
pulisher
Aug 05, 2024

Incannex Healthcare gets FDA nod for Phase 2 trial - Green Market Report

Aug 05, 2024
pulisher
Aug 05, 2024

FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to Proceed - StockTitan

Aug 05, 2024
pulisher
Aug 04, 2024

Tidal Investments LLC Buys New Stake in Incannex Healthcare Inc. (NASDAQ:IXHL) - MarketBeat

Aug 04, 2024
pulisher
Aug 04, 2024

Tidal Investments LLC Acquires Shares of 423,410 Incannex Healthcare Inc. (NASDAQ:IXHL) - Defense World

Aug 04, 2024
pulisher
Jul 30, 2024

Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42X - GlobeNewswire

Jul 30, 2024

Finanzdaten der Incannex Healthcare Inc-Aktie (IXHL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$90.27
price up icon 0.83%
$13.13
price up icon 0.00%
$86.59
price up icon 0.19%
$61.00
price up icon 0.41%
$126.59
price down icon 1.03%
$13.22
price up icon 1.07%
Kapitalisierung:     |  Volumen (24h):